Stock Fundamentals

Company Information

Company Name
ASP Isotopes Inc. Common Stock
Sector
Basic Materials
Industry
Chemicals
Exchange
NASDAQ
ISIN: US00218A1051
CIK: 0001921865
Currency: USD
Full Time Employees: 271
Phone: 214 432 8219
Fiscal Year End: December
IPO Date: Nov 10, 2022
Description:

ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs. The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry. In addition, the company develops Zinc-68, Nickel-64, and Xenon-129/136 for the nuclear medical industry; Lithium-7, Uranium-235, and Chlorine-37 for the energy industry; and Germanium-70/72/74 for semiconductor markets. The company was incorporated in 2021 and is based in Dallas, Texas.

Address:

2200 Ross Avenue, Dallas, TX, United States, 75201

Directors & Officers

Name Title Year Born
Mr. Paul Elliot Mann C.F.A. Executive Chairman & CEO 1977
Ms. Heather Kiessling Chief Financial Officer 1965
Mr. Robert Ainscow Chief Operating Officer 1977
Mr. Nicholas Michael Mitchell Co-Chief Operating Officer 1980
Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. Chief Technology Officer 1961
Mr. Donald George Ainscow EVP, General Counsel & Secretary 1981
Mr. Hendrik T. van Wyk Head of Engineering NA
Dr. Xandra van Heerden Ph.D. Head of Research & Development NA
Mr. Stefano Marani President of Electronics & Space 1978
Dr. Gerdus Kemp M.D., Ph.D. Medical Director & CEO of Pet Labs NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 16, 2026 Robert Ainscow N/A Sale 22.50K $5.21 $117.23K
Apr 16, 2026 Duncan Moore N/A Sale 11.64K $5.21 $60.65K
Apr 15, 2026 Heather Kiessling N/A Sale 23.12K $5.48 $126.72K
Mar 06, 2026 Robert Ainscow N/A Sale 8.44K $5.44 $45.90K
Mar 06, 2026 Robert Ainscow N/A Sale 25.00K $4.51 $112.75K
Dec 18, 2025 Heather Kiessling N/A Sale 80.00K $5.80 $464.00K
Dec 08, 2025 Robert Ainscow N/A Sale 8.44K $6.20 $52.32K
Dec 01, 2025 Paul Elliot Mann N/A Sale 162.15K $5.75 $932.38K
Nov 25, 2025 Robert Ainscow N/A Sale 25.00K $5.77 $144.25K
Nov 25, 2025 Paul Elliot Mann N/A Sale 50.00K $5.77 $288.50K
Nov 17, 2025 Paul Elliot Mann N/A Sale 112.50K $7.51 $844.88K
Nov 17, 2025 Robert Ainscow N/A Sale 67.50K $7.51 $506.93K
Oct 14, 2025 Robert Ainscow N/A Sale 22.50K $13.60 $306.00K
Sep 30, 2025 Michael Gorley N/A Sale 64.00K $9.75 $624.00K
Sep 15, 2025 Todd Wider N/A Sale 74.11K $8.76 $649.19K
Sep 09, 2025 Paul Elliot Mann N/A Sale 81.08K $8.39 $680.24K
Sep 08, 2025 Paul Elliot Mann N/A Sale 81.08K $8.53 $691.58K
Sep 08, 2025 Robert Ainscow N/A Sale 8.44K $8.53 $71.98K
Aug 29, 2025 Duncan Moore N/A Sale 75.00K $9.28 $696.00K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 8.33M Mar 31, 2026 6.61% $0.00 22.66%
Encompass Capital Advisors LLC 6.91M Mar 31, 2026 5.49% $0.92 0.00%
Vanguard Group Inc 6.41M Dec 31, 2025 5.09% $0.00 41.83%
Rovida Investment Management Ltd 4.10M Mar 31, 2026 3.26% $2.27 0.00%
UBS Group AG 2.84M Mar 31, 2026 2.26% $0.00 18.09%
Geode Capital Management, LLC 2.74M Mar 31, 2026 2.18% $0.00 14.95%
Alyeska Investment Group, L.P. 2.69M Mar 31, 2026 2.14% $0.03 -45.01%
State Street Corp 2.32M Mar 31, 2026 1.84% $0.00 25.90%
Exchange Traded Concepts, LLC 2.18M Mar 31, 2026 1.73% $0.07 55.93%
Awm Investment Company Inc 2.12M Mar 31, 2026 1.69% $1.04 0.00%
Morgan Stanley - Brokerage Accounts 1.58M Mar 31, 2026 1.25% $0.00 -7.80%
Susquehanna International Group, LLP 1.06M Mar 31, 2026 0.84% $0.00 -30.28%
Barclays PLC 1.01M Mar 31, 2026 0.80% $0.00 99.88%
Diametric Capital, LP 953.51K Mar 31, 2026 0.76% $1.10 29.32%
Northern Trust Corp 937.52K Mar 31, 2026 0.74% $0.00 25.69%
Charles Schwab Investment Management Inc 897.24K Mar 31, 2026 0.71% $0.00 1.30%
BNP Paribas Investment Partners SA 887.25K Mar 31, 2026 0.70% $0.00 -6.04%
Citadel Advisors Llc 768.01K Mar 31, 2026 0.61% $0.00 -55.49%
Jane Street Group LLC 684.48K Mar 31, 2026 0.54% $0.00 -56.87%
Philadelphia Financial Mgmt Of San Franc 648.34K Mar 31, 2026 0.52% $0.83 0.00%

Shares Statistics

Shares Outstanding: 125.90M
Shares Float: 99.87M
% Insiders: 1,304.90%
% Institutions: 5,669.60%
Short % Float: 20.44%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 3.70M 2.94% ▲ 0.00% Apr 30, 2026
2 iShares Russell 2000 ETF 2.64M 2.10% ▲ 0.85% Apr 30, 2026
3 Range Nuclear Renaissance ETF 2.18M 1.73% ▲ 0.00% Apr 30, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 1.26M 1.00% ▲ 0.54% Apr 30, 2026
5 BNP Clean Energy Solutions C D 999.93K 0.79% ▲ 33.31% Apr 30, 2026
6 iShares Russell 2000 Growth ETF 928.40K 0.74% ▲ 0.26% Apr 30, 2026
7 Fidelity Small Cap Index 906.11K 0.72% ▲ 0.96% Feb 28, 2026
8 State St Russell Sm/Mid Cp® Indx SL Cl I 665.58K 0.53% ▲ 0.00% Apr 30, 2026
9 Fidelity Extended Market Index 595.79K 0.47% ▲ 3.60% Mar 31, 2026
10 Vanguard Russell 2000 ETF 573.99K 0.46% ▲ 2.64% Apr 30, 2026

Valuation Metrics

Enterprise Value: $979.81M
Trailing P/E: 0.00
Forward P/E: 54.35

Financial Highlights

Market Cap: $950.57M
EBITDA: $-69.91M
Book Value: $2.30
Earnings/Share: $-2.21
Profit Margin: 0.00%
Operating Margin: -595.41%
ROA (TTM): -13.66%
ROE (TTM): -103.32%
Revenue (TTM): $26.93M
Revenue/Share (TTM): $0.28
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 279.30%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 12.18x 1.05x 0.49x -99.46x -1.37x
2024-12-31 9.31x 0.76x 0.46x -101.81x -1.16x
2023-12-31 1.85x 0.05x 0.38x -135.32x -0.05x
2022-12-31 1.71x 0.01x 0.21x -33.13x -0.02x
2021-12-31 10.62x 0.01x 0.16x N/A -0.03x
2019-12-31 N/A N/A N/A N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ASPI.US!